Galapagos opens IND for GLPG0634 in the US
Mechelen, Belgium; 3 December 2012 – Galapagos NV (Euronext: GLPG) announced today that it has opened its Investigational New Drug application for GLPG0634 with the US Food and Drug Administration. Galapagos intends to conduct a …